Advanced Filters
noise

Taipei City, R.O.C., Taiwan Clinical Trials

A listing of Taipei City, R.O.C., Taiwan clinical trials actively recruiting patients volunteers.

Found 810 clinical trials

Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ASD141

This is a Phase I study designed to evaluate if ASD141 is safe, tolerable, and efficacious in participants with advanced solid tumors.

18 years of age All Phase 1

Susceptibility Testing Guided Versus Empirical Therapy for Refractory H. Pylori Infection

Aim: Therefore, we aimed to compare the efficacy of susceptibility testing guided therapy vs. empirical therapy in the third-line eradication for refractory H. pylori infection assess the long-term impact of eradication therapy on the antibiotic resistance and microbiota of the gut flora and the metabolic factors. Methods: This will be …

20 - 90 years of age All Phase 4
Y Yu-Ting Lin, MD

The Efficacy of Ultrasound Guided Transcutaneous Pulsed Radiofrequency for Cervical Radiculopathy: a Randomized, Sham-controlled, Double-blind Pilot Study

Cervical radiculopathy (CR) is a painful condition caused by irritation of the cervical nerve roots, often leading to neck, shoulder, and arm pain, sometimes with numbness or weakness. These symptoms can reduce quality of life and place a burden on healthcare systems. Current treatments, such as physical therapy, cervical traction, …

20 - 75 years of age All Phase N/A
C Chen Chia-Hui, PhD

Effectiveness of Pet-Robotic Intervention in Intensive Care Unit Patients

This study aims to develop a novel nursing intervention involving robotic pet companionship to reduce anxiety in patients undergoing spontaneous breathing trials.

18 years of age All Phase N/A
C ChaoWen Dr.

Feasibility of Tracheobronchial Defect Reconstruction Using Allogenic Aortic Patch

The investigators investigate the feasibility and safety of using cryopreserved aortic patches for tracheal or bronchial defect repair.

18 years of age All Phase N/A
J Jiunn-Kae Wang, MD, MSc

Neurobiological Investigations of Mindfulness, Depression and Sleep Disturbances in Medical Staffs and Community Elders

The research team proposes a multi-year study with the first year focusing on the developmental phase. In this initial phase, we aim to recruit 40 participants (including healthcare staff and older adults) from Shuang-Ho Hospital and the surrounding community to undergo two mindfulness intervention sessions, each lasting four months. We …

20 - 90 years of age All Phase N/A
W WEN-HUI FANG, Ph. D.

Effect of ANKASCIN 568-P Products Regulating Blood Lipid

This study is a randomized, double-blind, placebo-controlled, parallel-controlled trial (24 weeks in total), divided into three periods (screening, treatment, and discontinuation follow-up)

20 years of age All Phase N/A
W Wei-Li Hsu, PhD

Digital Health for Lumbar Degeneration

This study will integrate wireless wearable sensors, smartphone imaging, and multimodal artificial intelligence (AI) to address the rehabilitation needs of patients with lumbar degeneration. Patients will undergo comprehensive functional assessments, and individualized exercise instruction with real-time feedback will be provided through a smartphone application. The goals of this research are …

50 - 80 years of age All Phase N/A
Y Yi Ling Chien, Clinical Professor

Motor Function Assessment and VR-based Motor Training in Adults With Autism Spectrum Disorder

The goal of this clinical trial is to learn if autism affect motor functions, including muscle strength, balance, and motor control? Additionally, understanding the motor functions, cognitive functions, and brain activation in individuals with autism, and verifying whether motor training can effectively improve muscle strength, balance, and motor control. The …

18 - 45 years of age All Phase N/A

Evaluate Efficacy and Safety of Repeat Subcutaneous Doses of FB825 in Adults With Moderate-to-Severe Atopic Dermatitis

This is a randomized, placebo-controlled and double-blind study to evaluate the efficacy, pharmacokinetics, and Safety of repeat subcutaneous doses of FB825 in adults with moderate-to-severe atopic dermatitis.

18 - 65 years of age All Phase 2

Simplify language using AI